Filter
1156
Filtered Results: 1156
Text search:
and
K.R.
Smith
Featured
Recommendations
90
New Publications
164
Language
Document type
No document type
530
Studies & Reports
300
Guidelines
203
Manuals
64
Strategic & Response Plan
20
Fact sheets
17
Training Material
13
Situation Updates
4
Infographics
3
Resource Platforms
2
Countries / Regions
Global
51
India
30
Western and Central Europe
25
South Africa
23
Russia
23
Latin America and the Carribbean
22
Brazil
16
Africa
15
Kenya
13
Eastern Europe
13
Myanmar / Burma
12
Mozambique
11
Sierra Leone
10
Malawi
10
Ukraine
10
Uganda
9
Germany
9
Tanzania
9
Argentina
9
Ethiopia
8
Liberia
7
Senegal
7
Indonesia
7
Middle East and North Africa
7
Nigeria
6
Congo, Democratic Republic of
6
Cameroon
6
Philippines
6
Nepal
6
Syria
6
South–East Asia Region
6
Spain
6
Burkina Faso
5
Ghana
5
Zimbabwe
5
Zambia
5
Bangladesh
5
West and Central Africa
5
Guinea
4
Haiti
4
Benin
4
Lesotho
4
Asia
4
Venezuela
4
Pakistan
3
Thailand
3
Colombia
3
Botswana
3
Angola
3
Chile
3
East and Southern Africa
3
Vietnam
3
USA
2
South Sudan
2
Afghanistan
2
Sudan
2
Peru
2
Yemen
2
Eastern Europe and Central Asia
2
Paraguay
2
Southern Africa
2
North America
2
United Kingdom
2
Portugal
2
Mali
1
Guinea-Bissau
1
Saudi Arabia
1
Chad
1
Cambodia
1
China
1
Malaysia
1
Singapore
1
Namibia
1
North Macedonia
1
Burundi
1
Madagascar
1
Mexico
1
Nicaragua
1
Sri Lanka
1
Western Pacific Region
1
Italy
1
Armenia
1
Canada
1
Kyrgyzstan
1
Georgia
1
Uruguay
1
Japan
1
Belgium
1
France
1
Belarus
1
Israel
1
Latvia
1
Authors & Publishers
Publication Years
Category
Countries
260
Clinical Guidelines
107
Public Health
81
Women & Child Health
60
Key Resources
25
Capacity Building
9
Pharmacy & Technologies
8
Toolboxes
Mental Health
179
COVID-19
159
Planetary Health
105
HIV
101
TB
65
NCDs
46
Caregiver
40
Disability
39
AMR
29
NTDs
28
Global Health Education
27
Ebola
22
Pharmacy
17
Rapid Response
15
Conflict
11
Health Financing Toolbox
10
Social Ethics
8
Polio
7
Natural Hazards
7
Zika
6
Specific Hazards
5
Refugee
4
Cholera
2
Health Financing
1
This Global Competency Standards sets the benchmark for the health workforce in providing equality of care to refugees and migrants. Refugee and migrant populations are highly diverse, with signific...
Climate Change 2021: The Physical Science Basis. Contribution of Working Group I to the Sixth Assessment Report of the Intergovernmental Panel on Climate Change
The 2021 WHO health and climate change global survey report provides a valuable snapshot of the overall progress governments have made in addressing the health risks of climate change. The findings on key health ... climate change indicators aim to empower policy makers to: make informed decisions on the implementation of policies and plans; identify evidence gaps; and better understand the barriers to achieving adaptation and resilience priorities in the health sector while maximizing the health benefits of sector-wide climate mitigation efforts.
Mosquito-borne diseases are expanding their range, and re-emerging in areas where they had subsided for decades. The extent to which climate change influences the transmission suitability and popula...
Int. J. Environ. Res. Public Health 2018, 15(12), 2626; https://doi.org/10.3390/ijerph15122626
Climate change is increasing risks to human health and to the health systems that seek to protect the safety ... well-being of populations. Health authorities require information about current associations between health outcomes and weather or climate, vulnerable populations, projections of future risks and adaptation opportunities in order to reduce exposures, empower individuals to take needed protective actions and build climate-resilient health systems. An increasing number of health authorities from local to national levels seek this information by conducting climate change and health vulnerability and adaptation assessments. While assessments can provide valuable information to plan for climate change impacts, the results of many studies are not helping to build the global evidence-base of knowledge in this area. They are also often not integrated into adaptation decision making, sometimes because the health sector is not involved in climate change policy making processes at the national level. Significant barriers related to data accessibility, a limited number of climate and health models, uncertainty in climate projections, and a lack of funding and expertise, particularly in developing countries, challenge health authority efforts to conduct rigorous assessments and apply the findings. This paper examines the evolution of climate change and health vulnerability and adaptation assessments, including guidance developed for such projects, the number of assessments that have been conducted globally and implementation of the findings to support health adaptation action. Greater capacity building that facilitates assessments from local to national scales will support collaborative efforts to protect health from current climate hazards and future climate change. Health sector officials will benefit from additional resources and partnership opportunities to ensure that evidence about climate change impacts on health is effectively translated into needed actions to build health resilience.
Annals of Global Health, 87(1), p.30. DOI: http://doi.org/10.5334/aogh.2647
Introduction: Considering the global prevalence of coronavirus disease 2019 (COVID-19), a vaccine is being developed to control the disease as a complementary solution to hygiene measures—and better, in social terms, than social distancing. Given ...
Curr HIV/AIDS Rep. 2022; 19(1): 37–45.
Published online 2022 Jan 29. doi: 10.1007/s11904-021-00589-4.
COVID-19 has had an unprecedented impact on the cascade-of-care among PLWH in LAC. There is a need for
longitudinal studies that assess clinic implication of these pandemic interactions in LAC.
Human Papilloma Virus (HPV) is the most common sexually transmitted infection, and two types of HPV (16 and 18) cause nearly 50% of high-grade cervical pre-cancers. HIV ... cervical cancer are inextricably linked. Women living with HIV are six times more likely to develop cervical cancer, which is one of the AIDS-defining illnesses and the most common cancer among women living with HIV globally. Cervical cancer is a preventable, curable disease and can be eliminated as a public health problem with primary and secondary prevention, treatment, and care of cervical cancer, in combination with addressing social, health and other inequalities and integrated approaches.
Theodor Bilharz, a German professor of anatomy and chief of surgery at the Kasr El Ani Hospital of Cairo from 1850, first identified an infective organism, Distomum hematobium in 1851, which was renamed Schistosoma haematobium in 1858. It arose from...
Schistosomiasis is a neglected tropical disease of global medical and veterinary importance. As efforts to eliminate schistosomiasis as a public health problem and interrupt transmission gather mome...
Human schistosomiasis, a parasitic and often chronic illness, is one of the major neglected tropical diseases worldwide. It is estimated that 240 million people suffer from schistosomiasis, with more than 200000 fatalities recorded each year. Schist...
The major neglected tropical diseases, Taenia solium taeniosis/cysticercosis and schistosomiasis caused by Schistosoma mansoni or S. haematobium are presumed to be widely distributed in Africa. Taenia solium taeniosis/ cysticercosis has been reporte...
Pregnancy and childbirth during adolescence profoundly affects the lives of millions of girls worldwide, and is a leading cause of maternal mortality and<...
Prevention of stroke and transient ischemic attack includes both conventional approaches to vascular risk factor management (blood pressure lowering, cholesterol reduction with statins, smoking cessation a... antiplatelet therapy)
and more specific interventions, such as carotid revascularization or anticoagulation for atrial fibrillation. The objective of this review is to discuss effective interventions for optimal primary and secondary stroke prevention.
Background
Low- and middle-income countries now experience the highest prevalence and mortality rates of cardiovascular disease.
Main text
While improving the availability ... delivery of proven, effective therapies will no doubt mitigate this burden, we posit that studies evaluating cardiovascular disease risk factors, management strategies and service delivery, in diverse settings and diverse populations, are equally critical to improving outcomes in low- and middle-income countries. Focusing on examples drawn from four cardiovascular diseases — coronary artery disease, stroke, diabetes and kidney disease — we argue that ethnicity, culture and context matter in determining the risk factors for disease as well as the comparative effectiveness of medications and other interventions, particularly diet and lifestyle interventions.
Conclusion
We believe that a host of cohort studies and randomized control trials currently being conducted or planned in low- and middle-income countries, focusing on previously understudied race/ethnic groups, have the potential to increase knowledge about the cause(s) and management of cardiovascular diseases across the world.
To improve survival and quality of life among the 2.5 million children living with HIV, a comprehensive package of prevention, care and treatment is required. This package should include management ...
The WHO COVID-19 LENS (Living Evidence Synthesis) working group consolidated available evidence, based on rapid reviews of the literature and results of a living systematic review on pregnancy and C...
This document provides guidance on the application of non-pharmaceutical countermeasures to minimise the spread of the 2019 novel coronavirus (2019-nCoV) in the population. Some of the measures proposed refer specifically to certain phases of the epidemic (containment or mitigation phases), ... can be adapted depending on the assessed severity/impact of the infection. Other measures are valid for all phases of an epidemic.
The guidance is based on the current knowledge of the 2019-nCoV and evidence available on other viral respiratory pathogens, mainly the Severe Acute Respiratory Syndrome coronavirus (SARS-CoV), the Middle East Respiratory Syndrome-related coronavirus (MERS-CoV) and seasonal or pandemic influenza viruses.
Policy
July 2012
Working Paper No. 3
